Skip to main content
[Preprint]. 2023 Jan 27:rs.3.rs-2488327. [Version 1] doi: 10.21203/rs.3.rs-2488327/v1

Figure 2. Comparison of PERSEVERE-CPB to validated risk-assessment tools to predict persistent MODS.

Figure 2

PERSEVERE-CPB functioned well as a predictor of multiple organ dysfunction syndrome, with cross-validation area under the curve (AUC) that was comparable to validated risk-assessment tools in our cohort. PERSEVERE: PERSEVERE-CPB biomarker prediction model, STAT: Society of Thoracic Surgery-European Association for Cardiothoracic Surgery mortality category, PRISM-III (pre): Pediatric Risk of Mortality score calculated using preoperative data, PRISM-III (post): Pediatric Risk of Mortality score calculated using data from the first 24 hours after surgery, PELOD-2: Pediatric Logistic Organ Dysfunction Score-2